I'll pass on the Chemo, Pass the apricots

An austrailian paper carried the story of Paul Reid last week, who was diagnosed with incurable lymphoma over a decade ago.

He's still alive today. According to him, the secret to his success is apricot kernels - thirty a day.

Reid turned down chemotherapy, vowing to eat himself well. Today, after over 13 years in remission, it's hard to argue the point. He's 68-years old and believes that ''cancer-killing'' properties in the kernels he still eats daily, coupled with a strict vegan diet and prayer, have cured him.

Reid isn't alone. There are a growing number of cancer patients who are looking toward food or other alternative treatments as the key to their survival. The trend is a worrisome one for medical professionals.

That's the party line, fo course, and I don't blame them. Some people are risking their lives by choosing to embark on unproven diets.
Actually, it's not the diets that worry them. Thirty apricot kernals a day isn't going to hurt anyone. Well, unless they choke. But it's the patients who are turning down medical treatment and putting their faith in ''anti-cancer'' diets tht has health care providers running scared.

To naysayers, Reid argues simply this point: ''So what if there's no scientific proof? What has a person to lose by going on an organic diet?'' he asks. ''I don't think my journey has been unscientific, it's just that there's been no science in a big way applied to it.''

It's an interesting argument. And while I am huge supporter of the many wonderful advances in oncology, I also respect each person's right to choose what seem like the best course of treatment for themselves.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap